Medical Devices

Medical Devices
Product Description

The EU Medical Device Regulation (MDR) requires a more stringent characterization of products in the Medical Device field. The MDR is madatory for all new products and existing products have to comply by May 26th 2020. Tentamus Pharma Labs are equipped to support you in fulfilling MDR requirements. Biological endpoints (e.g. haemocompatibility, cytotoxicity, genotoxicity, irritation, etc…) as well as chemical characterization (e.g. extractable & leachable studies, etc…) is available at our laboratories. In addition to these analytical tests, medical testing for stents & stent graft, vascular graft, catheters, heart valves and other devices is available at Tentamus Pharma Labs. Contact us and arrange a meeting with our experts to learn more about our capabilities.

Tentamus Pharma and Med GmbH

  • DE
  • 2017
    On CPHI since
Company types
Contract Service
Specifications
  • Supplied from
    Austria; Germany; United Kingdom

Tentamus Pharma and Med GmbH

  • DE
  • 2017
    On CPHI since
Company types
Contract Service

More Products from Tentamus Pharma and Med GmbH (2)

  • Pharmaceutical Products

    Product Pharmaceutical Products

    Bringing a pharmaceutical product to the market entails many complex, time consuming and expensive activities. Analytical expertise is a cornerstone in this development process. Tentamus Pharma Labs can support our customers throught the entirety of the development process and commercialization by prov...
  • Biomolecules and ATMPs

    Product Biomolecules and ATMPs

    Biomolecules like antibodies have revolutionized the pharmaceutical industry during the last decade and new products (e.g. Advanced Therapy Medicinal Products – ATMPs) are evolving in clinical studies and on the market. Tentamus Pharma Labs are among the leaders of analytical support for these product ...